Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof
Patent Information
- Application Number
- MYPI2025000775
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-08-03
- Filing Date
- 2023-07-25
- Publication Date
- 2024-02-03
AI Technical Summary
Ergothioneine or its salt has an unpleasant bitter taste, making it challenging to incorporate into oral compositions effectively, as existing technologies have not adequately addressed the bitterness suppression issue.
Combining ergothioneine or its salt with porcine-derived collagen having a weight average molecular weight of 1,000 to 10,000, with a weight ratio of 5 to 700, to effectively suppress the bitterness and odor in oral compositions.
The combination significantly reduces the bitterness and odor of ergothioneine, making it easier to ingest and increasing the palatability of oral compositions containing ergothioneine, thereby facilitating continuous intake.
Abstract
Description
Oral composition and method for suppressing bitterness derived from ergothioneine or its salt
[0001] The present invention relates to an oral composition containing ergothioneine or a salt thereof and porcine-derived collagen having a weight-average molecular weight of more than 1000 and not more than 10000. The present invention also relates to a method for suppressing the bitterness derived from ergothioneine or a salt thereof.
[0002] Ergothioneine is a hydrophilic sulfur-containing amino acid known to have various physiological activities, including antioxidant activity. Regarding the physiological activities of ergothioneine, for example, Patent Document 1 reports that it has the effect of activating immune responses and promoting cytokine production. Due to its diverse physiological activities, ergothioneine has recently attracted attention for use in foods, cosmetics, and pharmaceuticals.
[0003] Japanese Patent Application Laid-Open No. 2017-218431
[0004] As described above, ergothioneine has useful physiological activities, and therefore foods such as supplements containing ergothioneine or its salts are useful for maintaining or improving health. However, ergothioneine or its salts have a unique flavor, particularly an unpleasant bitter taste that stings the tongue, and there is room for improvement in terms of formulation into oral compositions.
[0005] An object of the present invention is to provide an oral composition containing ergothioneine or a salt thereof, in which the bitterness derived from ergothioneine or a salt thereof is reduced. Another object of the present invention is to provide a method for suppressing the bitterness derived from ergothioneine or a salt thereof in an oral composition containing ergothioneine or a salt thereof.
[0006] As a result of intensive research conducted by the present inventors to solve the above-mentioned problems, they found that the bitterness derived from ergothioneine or a salt thereof can be effectively suppressed by combining ergothioneine or a salt thereof with porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000.
[0007] The present invention includes the following compositions, etc. [1] An oral composition containing the following components (A) and (B): (A) ergothioneine or a salt thereof, and (B) porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000. [2] The oral composition according to [1] above, in which the weight ratio of component (B) to component (A) (in ergothioneine equivalent), ((B) / (A)), is 5 to 700. [3] The oral composition according to [1] or [2] above, which is a food or beverage. [4] A method for suppressing the bitterness derived from ergothioneine or a salt thereof in an oral composition containing (A) ergothioneine or a salt thereof, the method comprising the step of blending (B) porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000 into the oral composition. [5] The method according to the above-mentioned [4], wherein component (B) is blended so that the weight ratio ((B) / (A)) of component (B) to component (A) (in terms of ergothioneine) in the oral composition is 5 to 700.
[0008] According to the present invention, an oral composition containing ergothioneine or a salt thereof in which the bitterness derived from ergothioneine or a salt thereof is reduced can be provided. Furthermore, according to the present invention, a method for suppressing the bitterness derived from ergothioneine or a salt thereof in an oral composition containing ergothioneine or a salt thereof can be provided.
[0009] The oral composition of the present invention (hereinafter also referred to as "the composition of the present invention") contains (A) ergothioneine or a salt thereof, and (B) porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000.
[0010] Ergothioneine is a type of sulfur-containing amino acid. In the present invention, ergothioneine is preferably L-ergothioneine. The salt of ergothioneine is not particularly limited as long as it is a pharmacologically acceptable salt or a salt acceptable for use in foods and beverages, and may be either an acid salt or a basic salt. Examples of acid salts include inorganic acid salts such as hydrochloride, sulfate, nitrate, and phosphate; and organic acid salts such as acetate, citrate, maleate, malate, oxalate, lactate, succinate, fumarate, and propionate. Examples of basic salts include alkali metal salts such as sodium salt and potassium salt; and alkaline earth metal salts such as calcium salt and magnesium salt.
[0011] Ergothioneine or a salt thereof is not limited in any way by its form, production method, etc. Ergothioneine or a salt thereof may be a chemically synthesized product, or may be extracted and purified from a natural product. L-ergothioneine is contained in large amounts in the golden / yellow oyster mushroom (scientific name: Pleurotus cornucopiae var. citrinopileatus), a mushroom of the Pleurotus genus in the family Pleurotus. L-ergothioneine is found in mushrooms such as white button mushrooms, crimini mushrooms, and portabella mushrooms (Agaricus bisporus), oyster mushrooms (Grey Oyster Mushroom) (Pleurotus ostreatus), shiitake mushrooms (Lentinula edodes), maitake mushrooms (Grifola Frondosa), reishi mushrooms (Ganoderma lucidum), Yamabushitake mushrooms (Hericium erinaceus), willow matsutake mushrooms (Agrocybe aegerita), and chanterelle mushrooms (Cantharella verruca). It is also contained in mushrooms such as mushrooms such as Pleurotus cibarius, porcini mushroom (scientific name: Boletus edulis), and morel mushroom (scientific name: Morchella esculenta). When obtaining L-ergothioneine from a natural product, it is preferably extracted from Pleurotus cornucopiae. Ergothioneine or a salt thereof can also be produced by microbial fermentation. Ergothioneine or a salt thereof may be isolated.
[0012] In the present invention, "collagen" generally refers to collagen protein. The production method of collagen is not particularly limited as long as it is derived from pigs. "Collagen" in the present invention also includes collagen peptides obtained by subjecting pig-derived collagen or denatured collagen such as gelatin to hydrolysis treatment with enzymes, acids, alkalis, etc. One type of collagen may be used alone, or two or more types of collagen may be used in combination.
[0013] The enzyme used in the hydrolysis treatment may be any enzyme capable of cleaving the peptide bonds of collagen or gelatin, such as collagenase, papain, bromelain, actinidin, ficin, cathepsin, pepsin, chymosin, trypsin, and enzyme preparations containing a mixture of these enzymes. Examples of acids that can be used include hydrochloric acid, sulfuric acid, and nitric acid. Examples of alkalis that can be used include sodium hydroxide and calcium hydroxide.
[0014] In the present invention, an aqueous solution of hydrolyzed collagen may be used as is, or may be powdered by drying or the like. Furthermore, the aqueous solution may be subjected to a commonly used purification treatment and used in the form of an aqueous solution, powder, or the like.
[0015] Commercially available collagen may be used, and collagen having a weight-average molecular weight of more than 1000 and not more than 10000 can be used. Examples of commercially available collagen include "SCP-50NB" (manufactured by Nitta Gelatin Co., Ltd.).
[0016] The weight-average molecular weight of the collagen used in the present invention is greater than 1,000 and equal to or less than 10,000, preferably 1,500 to 9,500, and more preferably 2,000 to 9,000. If the weight-average molecular weight is 1,000 or less, the collagen may have a strong bitter taste accompanied by an odor specific to low-molecular-weight collagen, while if it is greater than 10,000, the collagen may have low solubility and absorbability.
[0017] As used herein, the weight-average molecular weight of collagen refers to the value measured by the relative molecular mass measurement method for fish oligopeptide powder in accordance with the Chinese National Standard (GB Standard) GB / T 22729-2008. However, substitutes are used for the M451 and M189 reagents. The weight-average molecular weight in this method is calculated based on a relative molecular mass calibration curve showing the logarithmic relationship between retention time and relative molecular weight obtained by measuring, under the same conditions, cell pigment C (cytochrome C, M6500), Trasylol (aprotinin, M12500), Bacillus subtilis (bacitracin, M1450), glycine-glycine-tyrosine-arginine (M451), and glycine-glycine-glycine (M189), all of which have known molecular weights. The weight-average molecular weight in this invention refers to the weight-average molecular weight calculated using this method in terms of each standard.
[0018] The composition of the present invention contains collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000, thereby reducing the bitterness derived from ergothioneine or a salt thereof. This facilitates continuous intake of ergothioneine or a salt thereof. In the composition of the present invention, the weight ratio of component (B) to component (A) (in ergothioneine equivalent) ((B) / (A)) is not particularly limited, but may be 1 to 1,000. When the weight ratio of component (B) to component (A) (in ergothioneine equivalent) is within the above range, the bitterness derived from component (A) can be sufficiently suppressed.
[0019] Pig-derived collagen having a weight-average molecular weight of more than 1,000 but not exceeding 10,000 has a distinctive odor reminiscent of animal odor. Combining this collagen with ergothioneine or a salt thereof can also suppress the odor derived from the collagen. In the composition of the present invention, the weight ratio of component (B) to component (A) (in ergothioneine equivalent) ((B) / (A)) is preferably 5 to 700. This can sufficiently suppress the odor derived from component (B), making the composition easier to ingest. The weight ratio is more preferably 7 to 400, even more preferably 10 to 300, and particularly preferably 10 to 100. In this specification, the term "ergothioneine-equivalent amount" or similar expressions refers to the amount of component (A) when ergothioneine is used, and refers to the value obtained by multiplying the number of moles of the salt by the molecular weight of ergothioneine when component (A) is a salt of ergothioneine.
[0020] The content of ergothioneine or a salt thereof in the composition of the present invention is not particularly limited and can be set depending on the form, etc. The content of ergothioneine or a salt thereof in the composition of the present invention, calculated as ergothioneine, is, for example, preferably 0.1 wt% or more, more preferably 0.2 wt% or more, even more preferably 0.3 wt% or more, and preferably 50 wt% or less, more preferably 40 wt% or less, even more preferably 30 wt% or less, even more preferably 20 wt% or less, and particularly preferably 10 wt% or less. In one aspect, the content of ergothioneine or a salt thereof in the composition of the present invention, calculated as ergothioneine, is preferably 0.1 to 50 wt%, more preferably 0.1 to 40 wt%, even more preferably 0.2 to 30 wt%, even more preferably 0.2 to 20 wt%, and particularly preferably 0.3 to 10 wt%. When the composition of the present invention contains two or more types of ergothioneine or a salt thereof, the content of the ergothioneine or a salt thereof is the total content thereof. The ergothioneine content can be measured by high performance liquid chromatography (HPLC).
[0021] The content of porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000 contained in the composition of the present invention is not particularly limited and can be set depending on the form, etc. The content of the collagen contained in the composition of the present invention is, for example, preferably 1 wt% or more, more preferably 5 wt% or more, even more preferably 10 wt% or more, even more preferably 30 wt% or more, particularly preferably 50 wt% or more, and preferably 99.9 wt% or less, more preferably 99.8 wt% or less, and even more preferably 99.5 wt% or less. In one aspect, the content of the collagen contained in the composition of the present invention is preferably 1 to 99.9 wt%, more preferably 10 to 99.8 wt%, and even more preferably 50 to 99.5 wt%. When two or more types of collagen are contained, the content of the collagen refers to the total content of these collagens. The collagen content can be measured by HPLC.
[0022] The composition of the present invention preferably contains 1 to 100 mg of ergothioneine or a salt thereof, per daily intake for an adult, in terms of ergothioneine, more preferably 2 to 50 mg, even more preferably 5 to 25 mg, and particularly preferably 5 to 20 mg. The composition of the present invention preferably contains 500 to 20,000 mg of porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000, per daily intake for an adult, more preferably 1,000 to 15,000 mg, and even more preferably 3,000 to 10,000 mg.
[0023] Ergothioneine or a salt thereof and porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000 are compounds contained in natural products and foods and beverages, and are commonly consumed as food. From the viewpoint of safety, therefore, it is believed that ergothioneine or a salt thereof and porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000 pose few problems, even when ingested daily. The present invention can provide a composition that is highly safe and easy to ingest with reduced bitterness derived from ergothioneine or a salt thereof.
[0024] As described above, ergothioneine or a salt thereof is known to exhibit a variety of physiological activities and health functions, such as antioxidant activity, brain function improving effect, anti-aging effect, eye disease improving effect, whitening effect, ultraviolet absorption effect, melanin production suppression effect, reactive oxygen species scavenging effect, elastase activity inhibitory effect, wrinkle formation suppression effect, skin sagging suppression effect, autophagy promotion effect, etc. Therefore, the composition of the present invention can be suitably used for antioxidant activity, brain function improving effect, anti-aging effect, eye disease, whitening effect, ultraviolet absorption effect, melanin production suppression, reactive oxygen species scavenging effect, elastase activity inhibition effect, wrinkle formation suppression effect, skin sagging suppression effect, autophagy promotion effect, etc.
[0025] Collagen is known to have various health benefits, such as skin-beautifying effects such as improving skin moisture retention and elasticity, and improving blood fluidity, etc. The composition of the present invention contains porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000, and therefore can be used to obtain the above-mentioned effects exerted by collagen.
[0026] The compositions of the present invention can be used for either therapeutic (medical) or non-therapeutic (non-medical) purposes, the latter being a concept that does not include medical procedures, i.e., surgery, treatment, or diagnosis of humans.
[0027] The composition of the present invention can be in the form of a food or drink, a drug, a quasi-drug, a feed, etc. The composition of the present invention may be a material or a preparation to be incorporated into a food or drink, a drug, a quasi-drug, a feed, etc.
[0028] The composition of the present invention is an oral composition, and specific examples of oral compositions include foods and beverages, oral medicines, quasi-drugs, feeds, etc., preferably foods and beverages or oral medicines, more preferably foods and beverages.
[0029] The composition of the present invention may contain any additives and ingredients in addition to ergothioneine or a salt thereof and porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000, as long as the effects of the present invention are not impaired. These additives and ingredients can be selected depending on the form of the composition, and those generally usable for oral compositions such as foods and beverages, pharmaceuticals, quasi-drugs, and feed can be used. When the composition of the present invention is used as a food or beverage, pharmaceutical, quasi-drug, feed, or the like, there is no particular limitation on the production method, and it can be produced by a general method. In one aspect, the composition of the present invention may comprise ergothioneine or a salt thereof and porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000. The form of the oral composition of the present invention is not particularly limited, and may be a solid (powder, granules, tablet, etc.), liquid, paste, etc.
[0030] For example, when the composition of the present invention is used as a food or beverage, various foods and beverages can be prepared by blending ergothioneine or a salt thereof and porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000 with ingredients usable in foods and beverages (e.g., food materials, food additives used as needed, etc.). The foods and beverages are not particularly limited, and examples include general foods and beverages, health foods, health supplements, health drinks, functional foods, foods for specified health uses, and foods and beverages for patients. The health foods, health supplements, functional foods, foods for specified health uses, etc. can be used in various formulations such as fine granules, tablets, granules, powders, capsules, chewable tablets, dry syrups, syrups, liquids, beverages, drinks, and liquid diets.
[0031] When the composition of the present invention is used as a pharmaceutical or quasi-drug, for example, ergothioneine or a salt thereof and porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000 can be blended with a pharmacologically acceptable carrier, additives added as needed, and the like to produce a pharmaceutical or quasi-drug in various dosage forms. Such carriers, additives, and the like may be any pharmacologically acceptable carriers that can be used in pharmaceuticals or quasi-drugs, and examples thereof include one or more of excipients, binders, disintegrants, lubricants, antioxidants, colorants, etc. Dosage forms for oral administration of pharmaceuticals or quasi-drugs include liquids, tablets, powders, fine granules, granules, sugar-coated tablets, capsules, suspensions, emulsions, chewable tablets, and the like.
[0032] When the composition of the present invention is used as feed, ergothioneine or a salt thereof and porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000 may be blended into the feed. Feed also includes feed additives. Examples of feed include livestock feed for cows, pigs, chickens, sheep, horses, etc.; small animal feed for rabbits, rats, mice, etc.; and pet food for dogs, cats, small birds, etc.
[0033] The subject to which the composition of the present invention is ingested or administered (also referred to as the administration subject) is not particularly limited, and is preferably a human or a non-human mammal, more preferably a human.
[0034] The present invention also encompasses the following method: (A) A method for suppressing the bitterness derived from ergothioneine or a salt thereof in an oral composition containing ergothioneine or a salt thereof, the method comprising the step of blending (B) porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000 with the oral composition.
[0035] The above method makes it possible to effectively suppress the bitterness derived from ergothioneine or a salt thereof. In the above method, the ergothioneine or a salt thereof, the porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000, and preferred embodiments thereof are the same as those of the composition of the present invention described above.
[0036] In the above method, the blending ratio of component (B) to component (A) (in terms of ergothioneine) is not particularly limited, but a preferred range is the same as the weight ratio of component (B) to component (A) (in terms of ergothioneine) in the composition of the present invention. In particular, blending component (B) so that the weight ratio of component (B) to component (A) (in terms of ergothioneine) in the oral composition ((B) / (A)) is 5 to 700 is preferred, as this can suppress both the bitterness derived from component (A) and the odor derived from component (B).
[0037] The above-mentioned method can suppress the bitterness derived from ergothioneine or a salt thereof, but may be combined with other bitterness suppression methods, such as a method of adding a sweetener or a flavoring agent to a bitter component to prepare a formulation, a method of coating a bitter component with a sugar coating to prepare a formulation, or a method of encapsulating the bitter component to prepare a formulation.
[0038] In this specification, a numerical range expressed by a lower limit and an upper limit, i.e., "lower limit to upper limit," includes the lower limit and the upper limit. For example, a range expressed by "1 to 2" means 1 or more and 2 or less, including 1 and 2. In this specification, the upper limit and the lower limit may be any combination of ranges.
[0039] The present invention will be described in more detail below with reference to examples, although the present invention is not limited to these examples.
[0040] The materials used in the following evaluation tests are as follows: (A) Ergothioneine: a raw material containing 100% L-ergothioneine (B) Collagen: a raw material containing 100% porcine collagen with a weight-average molecular weight of 5,000
[0041] The weight-average molecular weight of collagen was measured using the relative molecular mass method for fish oligopeptide powder in accordance with the Chinese National Standard GB / T 22729-2008, except that the reagents for M,451 and M,189 were glycine-glycine-tyrosine-arginine (M,451) and glycine-glycine-glycine (M,189), respectively.
[0042] Example 1: Flavor evaluation test for oral compositions containing ergothioneine and collagen Oral compositions containing ergothioneine and collagen were prepared, and three panelists skilled in sensory evaluation performed sensory evaluations. The amounts of (A) and (B) shown in Table 1 were mixed to prepare compositions of Samples 1 to 6 (oral compositions containing ergothioneine and collagen). The weight ratio ((B) / (A)) of (B) collagen to (A) ergothioneine in each composition is shown in Table 1. Each panelist placed the entire amount of the prepared oral composition (for example, for Sample 1, a total of 20 mg, consisting of 10 mg ergothioneine and 10 mg collagen) directly on their tongues, and evaluated the intensity of the bitterness derived from ergothioneine and the intensity of the odor derived from collagen according to the following criteria.
[0043] (Evaluation criteria for bitterness derived from ergothioneine) Evaluation was carried out using the following criteria with a scale of 1 to 5 (5 levels). As the reference point, the intensity of the bitterness derived from ergothioneine felt when raw material (A) (10 mg) was placed on the tongue was assigned a score of 5 (Control 1). The evaluations of three panelists were compiled, and the average scores (scores) are shown in Table 1. 5 points: The bitterness derived from ergothioneine is strongly felt 4 points: The bitterness derived from ergothioneine is felt 3 points: The bitterness derived from ergothioneine is slightly felt 2 points: The bitterness derived from ergothioneine is not felt very much 1 point: The bitterness derived from ergothioneine is not felt
[0044] (Evaluation criteria for collagen-derived odor) Evaluation was made on a scale of 1 to 5 (5 levels) based on the following criteria. As a benchmark, the intensity of the collagen-derived bitterness felt when raw material (B) (10 mg) was placed on the tongue was given a score of 5 (Control 2). The evaluations of three panelists were compiled, and the average scores (scores) are shown in Table 1. 5 points: Strong collagen-derived odor 4 points: Collagen-derived odor is noticeable 3 points: Collagen-derived odor is slightly noticeable 2 points: Collagen-derived odor is barely noticeable 1 point: Collagen-derived odor is not noticeable
[0045]
[0046] <Results> We confirmed that the bitter taste derived from ergothioneine is suppressed by combining ergothioneine with collagen. Collagen alone has a strong odor making it difficult to ingest, but we confirmed that the odor can be reduced by combining it with an appropriate amount of ergothioneine.
Claims
1. An oral composition containing the following components (A) and (B): (A) ergothioneine or a salt thereof, and (B) porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000.
2. The oral composition according to claim 1, wherein the weight ratio ((B) / (A)) of component (B) to component (A) (in terms of ergothioneine) is 5 to 700.
3. The oral composition according to claim 1 or 2, which is a food or drink.
4. (A) A method for suppressing the bitterness derived from ergothioneine or a salt thereof in an oral composition containing ergothioneine or a salt thereof, the method comprising the step of blending (B) porcine-derived collagen having a weight-average molecular weight of more than 1,000 and not more than 10,000 with the oral composition.
5. The method according to claim 4, wherein component (B) is blended so that the weight ratio ((B) / (A)) of component (B) to component (A) (in terms of ergothioneine) in the oral composition is 5 to 700.
